SlideShare une entreprise Scribd logo
1  sur  38
Télécharger pour lire hors ligne
ANTI-PSYCHOTIC
DRUGS
Dr.RENJU.S.RAVI
CASE SCENARIO
 A 45 year old male patient was brought to the
casualty in agitated state .His wife complains
that he is agitated, talkative and keeps on
mumbling to himself and does not sleep well
at night. When asked about his mumbling, he
says that his wife and children are trying to
poison him. He has been talking to his
mother about this & believes that only she
can save him.( according to his wife , the
mother passed away 20 yrs ago)
 Family h/o  father & mother not alive.3 siblings.
One brother is admitted to mental asylum.
others normal. 2 children - both normal.
 Past h/o he had similar symptoms and was on
treatment, but discontinued as soon as his
symptoms disappeared.
 O/E—Well built, but poorly nourished. Poor
hygiene. Weight- 50 kg. He is anxious, worried
and suspicious of the interviewer. He is well
oriented, but keeps on talking to himself. All
systems within normal limits.
Biochemical parameters – normal, ECG- normal
 1) What is your diagnosis?
 Schizophrenia- paranoid (DSM-V-TR)
DSM-V-TR Diagnostic Criteria for Schizophrenia
Two (or more) of the following, each present for a significant
portion of time during a 1-month period
 delusions
 hallucinations
 disorganized speech grossly
 disorganized or catatonic behaviour
 negative symptoms, i.e., affective flattening, alogia, avolition,
anhedonia
 Treatment was started and within 2 weeks he
became less agitated and started taking interest in
himself & surroundings & became more co-
operative. Sleeps well at night. After 4 weeks of
treatment, he began to socialise with his family and
neighbours but still continues to have auditory
hallucinations. Adequate dose adjustment was
done.
 After 6 months of treatment , all his symptoms
subsided. O/E – adequately nourished. Wt 63 kg.
Very co-operative. Answering to all questions.
 Biochemistry :RBS- 180 mg %. Urine sugar +ve
 others –normal, ECG – normal
PSYCHIATRIC DISORDERS
 2 Types - PSYCHOSIS / NEUROSIS
 PSYCHOSIS - Insight is absent
Refuses to take treatment
Schizophrenia & Mood disorders…
 NEUROSIS – Less serious ,insight is present
Anxiety, OCD, PTSD, Phobias …
 2) Name the older /classical /typical /1st
generation antipsychotics. (NEUROLEPTICS)
 A) Phenothiazines
 Chlorpromazine
 Triflupromazine
 Thioridazine
 Mesoridazine
 Fluphenazine
 Perphenazine
 Trifluoperazine
Aliphatic derivatives
Piperazine derivatives
Piperidene derivatives
 B) Thioxanthenes
 Thiothixene
 Chlorprothixene
 Flupenthixol
 C) Butyrophenone Derivatives
 Haloperidol
 Droperidol
 Penfluridol
D) Others
 Pimozide ,Loxapine, Molindone
Clinical classification
 Low potent:
eg .Chlorpromazine, Thioridazine
 Mid potent:
eg. Trifluperazine, Perphenazine
 High potent:
eg .Haloperidol, Fluphenazine,
Thiothixene
 3) Atypical / 2nd generation antipsychotics
 Clozapine
 Olanzapine
 Risperidone
 Quetiapine
 Aripiprazole
 Ziprasidone
 Lurasidone
 Paliperidone
 Iloperidone
 Sertindole
 Asenapine
 Zotepin
 Amisulpride
4. How will you treat his present agitated state?
 Treatment during the acute phase focuses on
alleviating the most severe psychotic symptoms. This
phase usually lasts from 4 to 8 weeks. Antipsychotics
and benzodiazepines can result in relatively rapid
calming of patients.
 Haloperidol
 Fluphenazine
 Olanzapine
 Ziprasidone
Less EPS
BZD
 Lorazepam (Ativan) has the advantage of reliable
absorption when it is administered either orally or
intramuscularly.
 The use of benzodiazepines may also reduce the
amount of antipsychotic that is needed to control
psychotic patients.
5) Name a drug that can be used immediately to control
his symptoms. Mention its route and onset of action?
Parenteral short acting drugs
Haloperidol- 5-10 mg intramuscular
Onset of action- 30-60 mts
repeated at 4-8 hrs for the first 24-72 hrs.
Other drugs- fluphenazine
olanzapine
ziprasidone
Other option- BZD
 6) Will you use injectable long acting depot
preparation to control his symptoms in acute
phase? Why?
 NO
 take months to reach a steady-state concentration and are
eliminated very slowly
 difficult to correlate clinical effect with dosage, and it is
extremely difficult to make dosage adjustments to manage
side effects.
 7) Name the drugs which are available as
long acting preparations. Mention its
indications?
 Fluphenazine
 Haloperidol long-acting decanoate injections
 Risperidone
 8) Once his agitation & other symptoms are
controlled, which drug can we use to stabilize
him?
 Any atypical agent to control symptoms
acute stage
stabilization stage
stable stage
 9) How long should you continue the treatment
for stabilisation?
 6 months
10) How does this drug act?
 Mesolimbic-mesocortical- behaviour, cognition
 Nigrostriatal- vol movement coordination
 Tuberoinfundibular – suppresses prolactin secretion
 Medullary periventricular – eating
 Incertohypothalamic – copulatory behaviour
 D2, 5HT2A,D4,D1 - Antagonism
Dopamine Psychosis
 11) What are its adverse effects?
1. Cardiovascular
2. Cerebrovascular
3. Neurological – EPS
4. Metabolic
5. Blood
6. Skin eruptions
7. Ocular
8. GI & hepatic S/E
 12) What is meant by SDA?
 Serotonin Dopamine Antagonist- second generation
antipsychotics.
13) Comment on the efficacy and potency of
antipsychotics.
Efficacy
 Positive symptoms- new drugs equal to old drugs
 Negative symptoms- newer ones are superior
Potency
 high (e.g., haloperidol)
 low (e.g., chlorpromazine),
 intermediate (e.g., loxapine)
 affinity for D2 receptor
 14) What are the extrapyramidal side effects
likely to occur?
REACTION FEATURES TIME OF MAXIMAL
RISK
TREATMENT
Acute dystonia Spasm of muscles of tongue,
face, neck, back; may mimic
seizures; not hysteria
1 to 5 days Antiparkinsonian agents are
diagnostic and curative
Akathisia Motor restlessness; not
anxiety or "agitation"
5 to 60 days Reduce dose or change
drug; antiparkinsonian
agents,a benzodiazepines or
propranolol b may help
Parkinsonism Bradykinesia, rigidity,
variable tremor, mask facies,
shuffling gait
5 to 30 days; can
recur even after a
single dose
Antiparkinsonian agents
helpfula
Neuroleptic
malignant
syndrome
Catatonia, stupor, fever,
unstable blood pressure,
myoglobinemia; can be fatal
Weeks; can persist
for days after
stopping neuroleptic
Stop neuroleptic
immediately; dantrolene or
bromocriptine c may help;
antiparkinsonian agents not
effective
Perioral tremor
("rabbit
syndrome")
Perioral tremor (may be a
late variant of parkinsonism)
After months or
years of treatment
Antiparkinsonian agents
often helpa
Tardive
dyskinesia
Oral-facial dyskinesia;
widespread choreoathetosis
or dystonia
After months or
years of treatment
(worse on
Prevention crucial;
treatment unsatisfactory
 15) What are the antipsychotics C/I in patients with
heart disease?
 Prolonged QT interval-
1. Thioridazine
2. Pimozide
3. High doses of haloperidol
4. Ziprasidone
 Myocarditis & cardiomyopathy-
 clozapine
16) What are the metabolic adverse effects likely
to occur with antipsychotics?
1. Weight gain- max- clozapine & olanzapine
 Risperidone produces intermediate weight gain
 Quetiapine and ziprasidone produce the least weight
gain.
2. Hyperglycemia ,hyperlipidemia, exacerbation of
existing type 1 and 2 DM, new-onset type 2 DM, and
diabetic ketoacidosis.
 17) Name the antipsychotic causing retinopathy.
 Thioridazine
 18) What are its other significant adverse effects?
Comment on the extrapyramidal A/E produced by
this drug.
 Low incidence of adverse EPS increased central
antimuscarinic activity
 Depressant effects on cardiac conduction and repolarization.
 Impaired ejaculation- alpha blockade, anticholinergic
 19) Name the antipsychotic producing
hypersalivation. Why does it cause that? how
will you treat it?
 Clozapine
 Muscarnic agonism at M4 receptors.
 Clonidine , anticholinergics, amitriptyline,scopolamine
patch, ipratropium sublingual spray ,atropine 1% solution,
botulinum toxin
 20) Name the longest acting antipsychotic. What
are its other advantages?
 Aripiprazole
Aripiprazole and its active metabolite – t½ 75 and 94 hrs
 Adv
 Long t ½
 partial DA agonist, enhance action at these receptors
when there is a low concentration of dopamine and would
block the actions of high concentrations of dopamine
 Min weight gain
 Lower EPS
 Produces no elevation of prolactin
 21) Mention the indications & contraindications
of clozapine?
 Treatment of refractory schizophrenia.
 Clozapine is the first drug to be FDA approved for an
antisuicide indication in schizophrenia pts.
Contraindications to clozapine
 H/o myeloproliferative disorder
 Uncontrolled epilepsy
 Paralytic ileus
 Clozapine-induced agranulocytosis or
granulocytopenia
 with caution
 patients who cannot tolerate anticholinergic
effects.
 at risk for drug-induced orthostasis.
 significant renal or hepatic disease.
22)How will you monitor a patient on clozapine?
Monitoring of WBC count
 Weekly monitoring- 6 months
 Every 3 weeks – next 6 months
 Monthly there after.
Monitoring of body weight, lipid profile, blood
glucose level also important.
 23) Name the antipsychotic with antianxiety &
antidepressant action. What are its advantages and
disadvantages?
 Ziprasidone – antianxiety & antidepressant
 Adv
 im formulation
 Min metabolic A/E, EPS, sedation
 Disadv
 Short t ½
 Cardiac depressant action
 24)Name the atypical agent preferred in autism?
What are its advantage and disadvantage ?
 Risperidone
ADV- similar to other atypical drugs, though EPS more than the
other atypical drugs
DISADV- hyperprolactinemia
 25) Name the only antipsychotic given sublingually.
 Asenapine
 26) Name a 1st generation antipsychotic with
metabolic side effects. ( Wt gain,
Hyperglycemia,Hypertriglyceremia)
 Chlorpromazine
27) Other uses of antipsychotic agents
 The older neuroleptics (most commonly prochlorperazine)
drug-induced nausea/vomiting.
 Intractable hiccups - Chlorpromazine.
 Tourette's disorder - Pimozide, Risperidone and haloperidol.
 Anxiety disorders (OCD,PTSD) – Quetiapine,Risperidone
 Huntington’s chorea
 Autism – Risperidone, Aripiprazole
 Neuroleptic anesthesia – Droperidol + Fentanyl
 Menon’s Lytic cocktail regime – CPZ + Pethidine
+Promethazine
THANK YOU!!!

Contenu connexe

Tendances

Tricyclic antidepressants
Tricyclic antidepressantsTricyclic antidepressants
Tricyclic antidepressantsLeeds Francisco
 
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Serotonin Norepinephrine Reuptake Inhibitors  (SNRIs)Serotonin Norepinephrine Reuptake Inhibitors  (SNRIs)
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)Sawsan Aboul-Fotouh
 
Selective serotonin reuptake inhibitors 2016
Selective serotonin reuptake inhibitors 2016Selective serotonin reuptake inhibitors 2016
Selective serotonin reuptake inhibitors 2016Mohamed Sedky
 
Antidepressants PHARMACOLOGY REVISION NOTES
Antidepressants PHARMACOLOGY REVISION NOTESAntidepressants PHARMACOLOGY REVISION NOTES
Antidepressants PHARMACOLOGY REVISION NOTESTONY SCARIA
 
Mood Stabilisers (Antimanic drugs)
Mood Stabilisers (Antimanic drugs)Mood Stabilisers (Antimanic drugs)
Mood Stabilisers (Antimanic drugs)Dr. Ashutosh Tiwari
 
Drug Therapy of Depression
Drug Therapy of Depression Drug Therapy of Depression
Drug Therapy of Depression Dr Htet
 
Antidepressants - Pharmacology
 Antidepressants - Pharmacology Antidepressants - Pharmacology
Antidepressants - PharmacologyAreej Abu Hanieh
 
Antidepressants -pharmacology
Antidepressants -pharmacologyAntidepressants -pharmacology
Antidepressants -pharmacologypavithra vinayak
 
Anti -depressants: classification & mechanism of action
Anti -depressants: classification & mechanism of actionAnti -depressants: classification & mechanism of action
Anti -depressants: classification & mechanism of actionDr. Kanishk Sharma
 
serotonin/neurotransmitter
serotonin/neurotransmitterserotonin/neurotransmitter
serotonin/neurotransmitterLollan Daran
 
Pharmacotherapy of antipsychotics
Pharmacotherapy of antipsychoticsPharmacotherapy of antipsychotics
Pharmacotherapy of antipsychoticsNovo Nordisk India
 

Tendances (20)

Antidepressants
AntidepressantsAntidepressants
Antidepressants
 
Tricyclic antidepressants
Tricyclic antidepressantsTricyclic antidepressants
Tricyclic antidepressants
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
Anti psychotic drugs
Anti psychotic drugsAnti psychotic drugs
Anti psychotic drugs
 
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Serotonin Norepinephrine Reuptake Inhibitors  (SNRIs)Serotonin Norepinephrine Reuptake Inhibitors  (SNRIs)
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
 
Selective serotonin reuptake inhibitors 2016
Selective serotonin reuptake inhibitors 2016Selective serotonin reuptake inhibitors 2016
Selective serotonin reuptake inhibitors 2016
 
Quetiapine
QuetiapineQuetiapine
Quetiapine
 
Antidepressants PHARMACOLOGY REVISION NOTES
Antidepressants PHARMACOLOGY REVISION NOTESAntidepressants PHARMACOLOGY REVISION NOTES
Antidepressants PHARMACOLOGY REVISION NOTES
 
Antidepressants
Antidepressants Antidepressants
Antidepressants
 
Benzodiazepines
BenzodiazepinesBenzodiazepines
Benzodiazepines
 
Mood Stabilisers (Antimanic drugs)
Mood Stabilisers (Antimanic drugs)Mood Stabilisers (Antimanic drugs)
Mood Stabilisers (Antimanic drugs)
 
Drug Therapy of Depression
Drug Therapy of Depression Drug Therapy of Depression
Drug Therapy of Depression
 
Antidepressants - Pharmacology
 Antidepressants - Pharmacology Antidepressants - Pharmacology
Antidepressants - Pharmacology
 
Typical antipsychotic
Typical antipsychoticTypical antipsychotic
Typical antipsychotic
 
Antidepressants -pharmacology
Antidepressants -pharmacologyAntidepressants -pharmacology
Antidepressants -pharmacology
 
Antianxiety drugs
Antianxiety drugsAntianxiety drugs
Antianxiety drugs
 
Anti -depressants: classification & mechanism of action
Anti -depressants: classification & mechanism of actionAnti -depressants: classification & mechanism of action
Anti -depressants: classification & mechanism of action
 
Anti-Dementia drugs
Anti-Dementia drugsAnti-Dementia drugs
Anti-Dementia drugs
 
serotonin/neurotransmitter
serotonin/neurotransmitterserotonin/neurotransmitter
serotonin/neurotransmitter
 
Pharmacotherapy of antipsychotics
Pharmacotherapy of antipsychoticsPharmacotherapy of antipsychotics
Pharmacotherapy of antipsychotics
 

En vedette (20)

Antipsychotics - drdhriti
Antipsychotics - drdhritiAntipsychotics - drdhriti
Antipsychotics - drdhriti
 
Antipsychotic drugs
Antipsychotic drugsAntipsychotic drugs
Antipsychotic drugs
 
Asenapine In Schizophrenia
Asenapine In SchizophreniaAsenapine In Schizophrenia
Asenapine In Schizophrenia
 
Sedatives hypnotic
Sedatives hypnoticSedatives hypnotic
Sedatives hypnotic
 
Mine ap
Mine apMine ap
Mine ap
 
Health (barbiturates drugs
Health (barbiturates drugsHealth (barbiturates drugs
Health (barbiturates drugs
 
Anti psychotics
Anti psychoticsAnti psychotics
Anti psychotics
 
Latuda (Lurasidone)
Latuda (Lurasidone)Latuda (Lurasidone)
Latuda (Lurasidone)
 
Anti psychotics
Anti psychoticsAnti psychotics
Anti psychotics
 
Antipsychotic agents & Lithium by Dr. Nadeem Korai
Antipsychotic agents & Lithium by Dr. Nadeem KoraiAntipsychotic agents & Lithium by Dr. Nadeem Korai
Antipsychotic agents & Lithium by Dr. Nadeem Korai
 
Atypical antipsychotics
Atypical antipsychoticsAtypical antipsychotics
Atypical antipsychotics
 
Anti psychotics
Anti psychoticsAnti psychotics
Anti psychotics
 
phases of clinical trial
phases of clinical trial phases of clinical trial
phases of clinical trial
 
Atypical antipsychotics
Atypical antipsychoticsAtypical antipsychotics
Atypical antipsychotics
 
Understanding psychosis
Understanding psychosisUnderstanding psychosis
Understanding psychosis
 
Schizophrenia Past, Present and Future
Schizophrenia Past, Present and FutureSchizophrenia Past, Present and Future
Schizophrenia Past, Present and Future
 
The neuroanatomical explanation for schizophrenia
The neuroanatomical explanation for schizophreniaThe neuroanatomical explanation for schizophrenia
The neuroanatomical explanation for schizophrenia
 
Psychosis
PsychosisPsychosis
Psychosis
 
Drug receptors
Drug receptorsDrug receptors
Drug receptors
 
Hypolipidemic agents
Hypolipidemic agentsHypolipidemic agents
Hypolipidemic agents
 

Similaire à Anti psychotic drugs

Quetiapine (Anti psychotic medicine)
Quetiapine (Anti psychotic medicine)Quetiapine (Anti psychotic medicine)
Quetiapine (Anti psychotic medicine)usra_ashraf
 
Antipsychotics ~ Management of Schizophrenia
Antipsychotics ~ Management of SchizophreniaAntipsychotics ~ Management of Schizophrenia
Antipsychotics ~ Management of SchizophreniaDr.Mohammad Hussein
 
quetiapine in BPD canmat 2018
quetiapine in BPD canmat 2018 quetiapine in BPD canmat 2018
quetiapine in BPD canmat 2018 Subodh Sharma
 
Management of adverse effect of antipsychotics 1
Management of adverse effect of antipsychotics 1Management of adverse effect of antipsychotics 1
Management of adverse effect of antipsychotics 1sadaf89
 
Typical antipsychotics
Typical   antipsychoticsTypical   antipsychotics
Typical antipsychoticsAnant Rathi
 
Brief overview of hypokinetic movement disorder
Brief overview of hypokinetic movement disorderBrief overview of hypokinetic movement disorder
Brief overview of hypokinetic movement disorderAhmad Shahir
 
Pharmacological treatment of schizophrenia
Pharmacological treatment of schizophreniaPharmacological treatment of schizophrenia
Pharmacological treatment of schizophreniajoanna1956
 
ANTIPSYCHOTIC TREATMENT.pptx
ANTIPSYCHOTIC TREATMENT.pptxANTIPSYCHOTIC TREATMENT.pptx
ANTIPSYCHOTIC TREATMENT.pptxSmithaRT1
 
Hanipsych, antipsychotics
Hanipsych,    antipsychoticsHanipsych,    antipsychotics
Hanipsych, antipsychoticsHani Hamed
 
Psychosis and antipsychotics (1)
Psychosis and antipsychotics (1)Psychosis and antipsychotics (1)
Psychosis and antipsychotics (1)Adonis Sfera, MD
 
Antidepressant_073002.pptx
Antidepressant_073002.pptxAntidepressant_073002.pptx
Antidepressant_073002.pptxShubhrimaKhan
 

Similaire à Anti psychotic drugs (20)

Case study of schizophrenia
Case study of schizophreniaCase study of schizophrenia
Case study of schizophrenia
 
Quetiapine (Anti psychotic medicine)
Quetiapine (Anti psychotic medicine)Quetiapine (Anti psychotic medicine)
Quetiapine (Anti psychotic medicine)
 
Antipsychotics update
Antipsychotics updateAntipsychotics update
Antipsychotics update
 
Antianxiety
AntianxietyAntianxiety
Antianxiety
 
Uses of Quetiapine
Uses of Quetiapine Uses of Quetiapine
Uses of Quetiapine
 
GROUP NO 6 PPT.pptx
GROUP NO 6 PPT.pptxGROUP NO 6 PPT.pptx
GROUP NO 6 PPT.pptx
 
Psychopharmacology prof satya
Psychopharmacology prof satyaPsychopharmacology prof satya
Psychopharmacology prof satya
 
Antipsychotics ~ Management of Schizophrenia
Antipsychotics ~ Management of SchizophreniaAntipsychotics ~ Management of Schizophrenia
Antipsychotics ~ Management of Schizophrenia
 
quetiapine in BPD canmat 2018
quetiapine in BPD canmat 2018 quetiapine in BPD canmat 2018
quetiapine in BPD canmat 2018
 
Management of adverse effect of antipsychotics 1
Management of adverse effect of antipsychotics 1Management of adverse effect of antipsychotics 1
Management of adverse effect of antipsychotics 1
 
Typical antipsychotics
Typical   antipsychoticsTypical   antipsychotics
Typical antipsychotics
 
Blonaserin
BlonaserinBlonaserin
Blonaserin
 
Brief overview of hypokinetic movement disorder
Brief overview of hypokinetic movement disorderBrief overview of hypokinetic movement disorder
Brief overview of hypokinetic movement disorder
 
Pharmacological treatment of schizophrenia
Pharmacological treatment of schizophreniaPharmacological treatment of schizophrenia
Pharmacological treatment of schizophrenia
 
ANTIPSYCHOTICS.pptx
ANTIPSYCHOTICS.pptxANTIPSYCHOTICS.pptx
ANTIPSYCHOTICS.pptx
 
ANTIPSYCHOTIC TREATMENT.pptx
ANTIPSYCHOTIC TREATMENT.pptxANTIPSYCHOTIC TREATMENT.pptx
ANTIPSYCHOTIC TREATMENT.pptx
 
Hanipsych, antipsychotics
Hanipsych,    antipsychoticsHanipsych,    antipsychotics
Hanipsych, antipsychotics
 
Psychosis and antipsychotics (1)
Psychosis and antipsychotics (1)Psychosis and antipsychotics (1)
Psychosis and antipsychotics (1)
 
Psychopharmacology
PsychopharmacologyPsychopharmacology
Psychopharmacology
 
Antidepressant_073002.pptx
Antidepressant_073002.pptxAntidepressant_073002.pptx
Antidepressant_073002.pptx
 

Plus de Dr Renju Ravi

Gastro seminar TDM of biologics in ibd
Gastro seminar TDM of biologics in ibdGastro seminar TDM of biologics in ibd
Gastro seminar TDM of biologics in ibdDr Renju Ravi
 
Biotransformation (Drug Metabolism)
Biotransformation (Drug Metabolism)Biotransformation (Drug Metabolism)
Biotransformation (Drug Metabolism)Dr Renju Ravi
 
Newer anti-platelets final.
Newer anti-platelets final.Newer anti-platelets final.
Newer anti-platelets final.Dr Renju Ravi
 
Pleiotropic effects of_statins
Pleiotropic effects of_statinsPleiotropic effects of_statins
Pleiotropic effects of_statinsDr Renju Ravi
 
Drug utilization studies
Drug utilization studiesDrug utilization studies
Drug utilization studiesDr Renju Ravi
 
Causality assessment scales
Causality assessment scalesCausality assessment scales
Causality assessment scalesDr Renju Ravi
 
Pharmacogenetics & Teratogenicity
Pharmacogenetics & TeratogenicityPharmacogenetics & Teratogenicity
Pharmacogenetics & TeratogenicityDr Renju Ravi
 
Oral anti coagulants ppt
Oral anti coagulants pptOral anti coagulants ppt
Oral anti coagulants pptDr Renju Ravi
 
Aprepitant Dr.Renju.S.Ravi
Aprepitant Dr.Renju.S.RaviAprepitant Dr.Renju.S.Ravi
Aprepitant Dr.Renju.S.RaviDr Renju Ravi
 

Plus de Dr Renju Ravi (20)

Gastro seminar TDM of biologics in ibd
Gastro seminar TDM of biologics in ibdGastro seminar TDM of biologics in ibd
Gastro seminar TDM of biologics in ibd
 
Off label use
Off label useOff label use
Off label use
 
Anti Amoebic Drugs
Anti Amoebic DrugsAnti Amoebic Drugs
Anti Amoebic Drugs
 
Biotransformation (Drug Metabolism)
Biotransformation (Drug Metabolism)Biotransformation (Drug Metabolism)
Biotransformation (Drug Metabolism)
 
Spare receptors
Spare receptorsSpare receptors
Spare receptors
 
Newer anti-platelets final.
Newer anti-platelets final.Newer anti-platelets final.
Newer anti-platelets final.
 
Pleiotropic effects of_statins
Pleiotropic effects of_statinsPleiotropic effects of_statins
Pleiotropic effects of_statins
 
Drug utilization studies
Drug utilization studiesDrug utilization studies
Drug utilization studies
 
Causality assessment scales
Causality assessment scalesCausality assessment scales
Causality assessment scales
 
Pharmacogenetics & Teratogenicity
Pharmacogenetics & TeratogenicityPharmacogenetics & Teratogenicity
Pharmacogenetics & Teratogenicity
 
B blockers
B blockersB blockers
B blockers
 
Oral anti coagulants ppt
Oral anti coagulants pptOral anti coagulants ppt
Oral anti coagulants ppt
 
Alpha blockers
Alpha blockersAlpha blockers
Alpha blockers
 
Soft steroids
Soft  steroidsSoft  steroids
Soft steroids
 
Confidence interval
Confidence intervalConfidence interval
Confidence interval
 
Aprepitant Dr.Renju.S.Ravi
Aprepitant Dr.Renju.S.RaviAprepitant Dr.Renju.S.Ravi
Aprepitant Dr.Renju.S.Ravi
 
Diazepam poisoning
Diazepam poisoningDiazepam poisoning
Diazepam poisoning
 
Phase 3 protocol
Phase 3 protocolPhase 3 protocol
Phase 3 protocol
 
Bioassay
BioassayBioassay
Bioassay
 
Anti thyroid drugs
Anti  thyroid drugsAnti  thyroid drugs
Anti thyroid drugs
 

Dernier

Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingSakthi Kathiravan
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 

Dernier (20)

Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursing
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 

Anti psychotic drugs

  • 2. CASE SCENARIO  A 45 year old male patient was brought to the casualty in agitated state .His wife complains that he is agitated, talkative and keeps on mumbling to himself and does not sleep well at night. When asked about his mumbling, he says that his wife and children are trying to poison him. He has been talking to his mother about this & believes that only she can save him.( according to his wife , the mother passed away 20 yrs ago)
  • 3.  Family h/o  father & mother not alive.3 siblings. One brother is admitted to mental asylum. others normal. 2 children - both normal.  Past h/o he had similar symptoms and was on treatment, but discontinued as soon as his symptoms disappeared.  O/E—Well built, but poorly nourished. Poor hygiene. Weight- 50 kg. He is anxious, worried and suspicious of the interviewer. He is well oriented, but keeps on talking to himself. All systems within normal limits. Biochemical parameters – normal, ECG- normal
  • 4.  1) What is your diagnosis?  Schizophrenia- paranoid (DSM-V-TR) DSM-V-TR Diagnostic Criteria for Schizophrenia Two (or more) of the following, each present for a significant portion of time during a 1-month period  delusions  hallucinations  disorganized speech grossly  disorganized or catatonic behaviour  negative symptoms, i.e., affective flattening, alogia, avolition, anhedonia
  • 5.
  • 6.  Treatment was started and within 2 weeks he became less agitated and started taking interest in himself & surroundings & became more co- operative. Sleeps well at night. After 4 weeks of treatment, he began to socialise with his family and neighbours but still continues to have auditory hallucinations. Adequate dose adjustment was done.  After 6 months of treatment , all his symptoms subsided. O/E – adequately nourished. Wt 63 kg. Very co-operative. Answering to all questions.  Biochemistry :RBS- 180 mg %. Urine sugar +ve  others –normal, ECG – normal
  • 7. PSYCHIATRIC DISORDERS  2 Types - PSYCHOSIS / NEUROSIS  PSYCHOSIS - Insight is absent Refuses to take treatment Schizophrenia & Mood disorders…  NEUROSIS – Less serious ,insight is present Anxiety, OCD, PTSD, Phobias …
  • 8.  2) Name the older /classical /typical /1st generation antipsychotics. (NEUROLEPTICS)  A) Phenothiazines  Chlorpromazine  Triflupromazine  Thioridazine  Mesoridazine  Fluphenazine  Perphenazine  Trifluoperazine Aliphatic derivatives Piperazine derivatives Piperidene derivatives
  • 9.  B) Thioxanthenes  Thiothixene  Chlorprothixene  Flupenthixol  C) Butyrophenone Derivatives  Haloperidol  Droperidol  Penfluridol D) Others  Pimozide ,Loxapine, Molindone
  • 10. Clinical classification  Low potent: eg .Chlorpromazine, Thioridazine  Mid potent: eg. Trifluperazine, Perphenazine  High potent: eg .Haloperidol, Fluphenazine, Thiothixene
  • 11.  3) Atypical / 2nd generation antipsychotics  Clozapine  Olanzapine  Risperidone  Quetiapine  Aripiprazole  Ziprasidone  Lurasidone  Paliperidone  Iloperidone  Sertindole  Asenapine  Zotepin  Amisulpride
  • 12. 4. How will you treat his present agitated state?  Treatment during the acute phase focuses on alleviating the most severe psychotic symptoms. This phase usually lasts from 4 to 8 weeks. Antipsychotics and benzodiazepines can result in relatively rapid calming of patients.  Haloperidol  Fluphenazine  Olanzapine  Ziprasidone Less EPS
  • 13. BZD  Lorazepam (Ativan) has the advantage of reliable absorption when it is administered either orally or intramuscularly.  The use of benzodiazepines may also reduce the amount of antipsychotic that is needed to control psychotic patients.
  • 14. 5) Name a drug that can be used immediately to control his symptoms. Mention its route and onset of action? Parenteral short acting drugs Haloperidol- 5-10 mg intramuscular Onset of action- 30-60 mts repeated at 4-8 hrs for the first 24-72 hrs. Other drugs- fluphenazine olanzapine ziprasidone Other option- BZD
  • 15.  6) Will you use injectable long acting depot preparation to control his symptoms in acute phase? Why?  NO  take months to reach a steady-state concentration and are eliminated very slowly  difficult to correlate clinical effect with dosage, and it is extremely difficult to make dosage adjustments to manage side effects.
  • 16.  7) Name the drugs which are available as long acting preparations. Mention its indications?  Fluphenazine  Haloperidol long-acting decanoate injections  Risperidone
  • 17.  8) Once his agitation & other symptoms are controlled, which drug can we use to stabilize him?  Any atypical agent to control symptoms acute stage stabilization stage stable stage
  • 18.  9) How long should you continue the treatment for stabilisation?  6 months
  • 19. 10) How does this drug act?  Mesolimbic-mesocortical- behaviour, cognition  Nigrostriatal- vol movement coordination  Tuberoinfundibular – suppresses prolactin secretion  Medullary periventricular – eating  Incertohypothalamic – copulatory behaviour  D2, 5HT2A,D4,D1 - Antagonism Dopamine Psychosis
  • 20.
  • 21.  11) What are its adverse effects? 1. Cardiovascular 2. Cerebrovascular 3. Neurological – EPS 4. Metabolic 5. Blood 6. Skin eruptions 7. Ocular 8. GI & hepatic S/E
  • 22.  12) What is meant by SDA?  Serotonin Dopamine Antagonist- second generation antipsychotics.
  • 23. 13) Comment on the efficacy and potency of antipsychotics. Efficacy  Positive symptoms- new drugs equal to old drugs  Negative symptoms- newer ones are superior Potency  high (e.g., haloperidol)  low (e.g., chlorpromazine),  intermediate (e.g., loxapine)  affinity for D2 receptor
  • 24.  14) What are the extrapyramidal side effects likely to occur?
  • 25. REACTION FEATURES TIME OF MAXIMAL RISK TREATMENT Acute dystonia Spasm of muscles of tongue, face, neck, back; may mimic seizures; not hysteria 1 to 5 days Antiparkinsonian agents are diagnostic and curative Akathisia Motor restlessness; not anxiety or "agitation" 5 to 60 days Reduce dose or change drug; antiparkinsonian agents,a benzodiazepines or propranolol b may help Parkinsonism Bradykinesia, rigidity, variable tremor, mask facies, shuffling gait 5 to 30 days; can recur even after a single dose Antiparkinsonian agents helpfula Neuroleptic malignant syndrome Catatonia, stupor, fever, unstable blood pressure, myoglobinemia; can be fatal Weeks; can persist for days after stopping neuroleptic Stop neuroleptic immediately; dantrolene or bromocriptine c may help; antiparkinsonian agents not effective Perioral tremor ("rabbit syndrome") Perioral tremor (may be a late variant of parkinsonism) After months or years of treatment Antiparkinsonian agents often helpa Tardive dyskinesia Oral-facial dyskinesia; widespread choreoathetosis or dystonia After months or years of treatment (worse on Prevention crucial; treatment unsatisfactory
  • 26.  15) What are the antipsychotics C/I in patients with heart disease?  Prolonged QT interval- 1. Thioridazine 2. Pimozide 3. High doses of haloperidol 4. Ziprasidone  Myocarditis & cardiomyopathy-  clozapine
  • 27. 16) What are the metabolic adverse effects likely to occur with antipsychotics? 1. Weight gain- max- clozapine & olanzapine  Risperidone produces intermediate weight gain  Quetiapine and ziprasidone produce the least weight gain. 2. Hyperglycemia ,hyperlipidemia, exacerbation of existing type 1 and 2 DM, new-onset type 2 DM, and diabetic ketoacidosis.
  • 28.  17) Name the antipsychotic causing retinopathy.  Thioridazine  18) What are its other significant adverse effects? Comment on the extrapyramidal A/E produced by this drug.  Low incidence of adverse EPS increased central antimuscarinic activity  Depressant effects on cardiac conduction and repolarization.  Impaired ejaculation- alpha blockade, anticholinergic
  • 29.  19) Name the antipsychotic producing hypersalivation. Why does it cause that? how will you treat it?  Clozapine  Muscarnic agonism at M4 receptors.  Clonidine , anticholinergics, amitriptyline,scopolamine patch, ipratropium sublingual spray ,atropine 1% solution, botulinum toxin
  • 30.  20) Name the longest acting antipsychotic. What are its other advantages?  Aripiprazole Aripiprazole and its active metabolite – t½ 75 and 94 hrs  Adv  Long t ½  partial DA agonist, enhance action at these receptors when there is a low concentration of dopamine and would block the actions of high concentrations of dopamine  Min weight gain  Lower EPS  Produces no elevation of prolactin
  • 31.  21) Mention the indications & contraindications of clozapine?  Treatment of refractory schizophrenia.  Clozapine is the first drug to be FDA approved for an antisuicide indication in schizophrenia pts.
  • 32. Contraindications to clozapine  H/o myeloproliferative disorder  Uncontrolled epilepsy  Paralytic ileus  Clozapine-induced agranulocytosis or granulocytopenia  with caution  patients who cannot tolerate anticholinergic effects.  at risk for drug-induced orthostasis.  significant renal or hepatic disease.
  • 33. 22)How will you monitor a patient on clozapine? Monitoring of WBC count  Weekly monitoring- 6 months  Every 3 weeks – next 6 months  Monthly there after. Monitoring of body weight, lipid profile, blood glucose level also important.
  • 34.  23) Name the antipsychotic with antianxiety & antidepressant action. What are its advantages and disadvantages?  Ziprasidone – antianxiety & antidepressant  Adv  im formulation  Min metabolic A/E, EPS, sedation  Disadv  Short t ½  Cardiac depressant action
  • 35.  24)Name the atypical agent preferred in autism? What are its advantage and disadvantage ?  Risperidone ADV- similar to other atypical drugs, though EPS more than the other atypical drugs DISADV- hyperprolactinemia
  • 36.  25) Name the only antipsychotic given sublingually.  Asenapine  26) Name a 1st generation antipsychotic with metabolic side effects. ( Wt gain, Hyperglycemia,Hypertriglyceremia)  Chlorpromazine
  • 37. 27) Other uses of antipsychotic agents  The older neuroleptics (most commonly prochlorperazine) drug-induced nausea/vomiting.  Intractable hiccups - Chlorpromazine.  Tourette's disorder - Pimozide, Risperidone and haloperidol.  Anxiety disorders (OCD,PTSD) – Quetiapine,Risperidone  Huntington’s chorea  Autism – Risperidone, Aripiprazole  Neuroleptic anesthesia – Droperidol + Fentanyl  Menon’s Lytic cocktail regime – CPZ + Pethidine +Promethazine

Notes de l'éditeur

  1. Perceptual misinterpretation of a real external stimulus. Compare with hallucination-ILLUSION
  2. long-acting depot medications can be useful for maintenance therapy in patients with a history of nonadherence to their oral medication and in those who prefer the convenience of long-acting or depot injections. In these situations, the oral form of available depot medications should be initiated first. If the oral form has been shown to be safe and effective, the patient can be converted to the depot form
  3. Agranulocytosis (granulocyte count less than 500/mm3) is a fatal side effect of antipsychotic drugs. The risk of agranulocytosis with clozapine is 1% and is greatest early in treatment, usually within the first 8 to 12 weeks of treatment. It tends to occur slightly more often in women, the elderly, and young patients (less than 21 years old).